Skip to main content

Table 2 Complete list of all reported adverse events in the study. Data are subdivided by the type of adverse effect. The adverse effects are ranked from most to least commonly reported. These data are presented from the 14 participants who completed the study. The n represents the raw number of subjects. The percentage was calculated from the 14 participants

From: Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain

Adverse events

Female (n)

Male (n)

All patients (n, % of participants)

Skin dryness

4

2

6, 43%

Rash

3

0

3, 21%

Cold sweats

0

1

1, 7%

Tachycardia

0

1

1, 7%